Search Results - "Chronic myeloid leukemia"

Protocols for Studying Graft-Versus-Leukemia Immunity in Mice

Sena, Catharina Lucas^Aff3, Gondim, Isadora Oliveira^Aff3, Ferreira, Elisabete Pisnitchenko^Aff3, da Silva, Sabrina Berger^Aff3, Antunes, Maísa Mota^Aff4, Castor, Marina Gomes Miranda^Aff5, Rezende, Barbara Maximino^Aff3

Sluyter, Ronald^Aff2, Walker, John M.^Aff1

Advancing Leukemia Management Through Liquid Biopsy: Insights into Biomarkers and Clinical Utility.

Hollanda, Cíntia Nogueira¹ (AUTHOR), Gualberto, Ana Cristina Moura¹ (AUTHOR), Motoyama, Andréa Barretto¹ (AUTHOR), Pittella-Silva, Fabio¹ (AUTHOR) pittella@unb.br

Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukemia-Blast Phase: A Single-Center Experience from South India.

Nakka, Thejeswar¹ (AUTHOR), Bhattacherjee, Arnab¹ (AUTHOR), Krishnamoorthi, Narendran¹ (AUTHOR), Tumathy, Divya Bala¹ (AUTHOR), Dahagama, Sindhu¹ (AUTHOR), Dubashi, Biswajit¹ (AUTHOR), Ganesan, Prasanth¹ (AUTHOR), Kayal, Smita¹ (AUTHOR) kayalsmita@gmail.com

Neddylation status determines the therapeutic sensitivity of tyrosine kinase inhibitors in chronic myeloid leukemia.

Zhang, Congyi¹ (AUTHOR), Yao, Yikai¹ (AUTHOR), Qian, Qiuting² (AUTHOR), Han, Xiongyu² (AUTHOR), Lu, Yunkun³ (AUTHOR), Jiang, Xinyi¹ (AUTHOR), Cheng, Hongqiang¹ (AUTHOR), Zhang, Xue¹ (AUTHOR), Chi, Ying² (AUTHOR) yingchi@intl.zju.edu.cn, Ke, Yuehai¹ (AUTHOR) yke@zju.edu.cn, Xiao, Peng^3,4 (AUTHOR) tulipxp@zju.edu.cn

BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake.

Mancini, Caterina¹ (AUTHOR), Menegazzi, Giulio² (AUTHOR), Peppicelli, Silvia² (AUTHOR), Versienti, Giampaolo² (AUTHOR), Guasti, Daniele¹ (AUTHOR), Pieraccini, Giuseppe³ (AUTHOR), Rovida, Elisabetta² (AUTHOR), Lulli, Matteo² (AUTHOR), Papucci, Laura² (AUTHOR), Dello Sbarba, Persio² (AUTHOR) persio.dellosbarba@unifi.it, Biagioni, Alessio² (AUTHOR) alessio.biagioni@unifi.it

An efficient leukemia prediction method using machine learning and deep learning with selected features.

Ilyas, Mahwish¹ (AUTHOR), Ramzan, Muhammad² (AUTHOR), Deriche, Mohamed³ (AUTHOR) m.deriche@ajman.ac.ae, Mahmood, Khalid⁴ (AUTHOR), Naz, Anam⁴ (AUTHOR)

Unusually indolent CML: a stable non-responder without complete cytogenetic remission for 30 years including 17 years on tyrosine kinase inhibitor therapy.

Shen, Qiudan¹ (AUTHOR), Tang, Guilin¹ (AUTHOR), Haddad, Fadi G.² (AUTHOR), Chen, Wenbo³ (AUTHOR), Wang, Wei J.¹ (AUTHOR), Wang, Wei¹ (AUTHOR), Wei, Qing¹ (AUTHOR), Medeiros, L. Jeffrey¹ (AUTHOR), Hu, Shimin¹ (AUTHOR) shu1@mdanderson.org

Safety profile of sikamat virus and its oncolytic potential in leukemic cells and cancer stem cells.

Siew, Zhen Yun¹ (AUTHOR) hfyzs1@nottingham.edu.my, Ong, Ghee Khang² (AUTHOR), Wong, Siew Tung² (AUTHOR) siewtung_wong@imu.edu.my, Leong, Pooi Pooi³ (AUTHOR), Tan, Boon Shing⁴ (AUTHOR), Leong, Chee-Onn⁴ (AUTHOR), Chupri, Juita Binti⁵ (AUTHOR), Fang, Chee-Mun¹ (AUTHOR), Voon, Kenny^1,2 (AUTHOR) kenny.voon@nottingham.edu.my

A rare case of cutaneous melioidosis manifesting as infective panniculitis: a case report.

Yongpisarn, Tanat¹ (AUTHOR), Santanirand, Pitak² (AUTHOR), Chairanaicharoen, Suwichak² (AUTHOR), Rattananukrom, Teerapong¹ (AUTHOR) teerpongrattananukrom@gmail.com

Allele-Specific PCR for Detection of Missense Mutations in the Chimeric BCR::ABL1 Gene Causing Failure of Tyrosine Kinase Inhibitor Therapy in CML Patients.

Skripkina, Anastasia¹ (AUTHOR), Fevraleva, Irina¹ (AUTHOR), Kuzmina, Elena¹ (AUTHOR), Biderman, Bella¹ (AUTHOR), Stepanova, Elena¹ (AUTHOR), Chelysheva, Ekaterina¹ (AUTHOR), Turkina, Anna¹ (AUTHOR), Sudarikov, Andrey¹ (AUTHOR) dusha@blood.ru

A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia.

Bica, Valeria¹ (AUTHOR), Venafra, Veronica^1,2 (AUTHOR), Massacci, Giorgia³ (AUTHOR), Graziosi, Simone¹ (AUTHOR), Gualdi, Sara² (AUTHOR), Minnella, Gessica^4,5 (AUTHOR), Sorà, Federica^4,5 (AUTHOR), Chiusolo, Patrizia^4,5 (AUTHOR), Brunetti, Maria Elsa⁶ (AUTHOR), Napolitano, Gennaro^6,7,8 (AUTHOR), Breccia, Massimo⁹ (AUTHOR), Mougiakakos, Dimitrios^10,11 (AUTHOR), Böttcher, Martin^10,11 (AUTHOR), Fischer, Thomas^10,11 (AUTHOR), Perfetto, Livia² (AUTHOR) livia.perfetto@uniroma1.it, Sacco, Francesca^3,6 (AUTHOR) francesca.sacco@uniroma2.it

Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives.

Pratiwi, Laras^1,2 (AUTHOR), Mashudi, Fawzia Hanum^1,2 (AUTHOR), Ningtyas, Mukti Citra^1,2,3 (AUTHOR), Sutanto, Henry^1,2,4 (AUTHOR) henry.sutanto-2022@fk.unair.ac.id, Romadhon, Pradana Zaky^3,4 (AUTHOR) zaky.romadhon@fk.unair.ac.id

Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.

Elbaz Younes, Ismail¹ (AUTHOR) elbaz008@umn.edu, Mroz, Pawel¹ (AUTHOR), Tashakori, Mehrnoosh¹ (AUTHOR), Hamed, Amira¹ (AUTHOR), Sen, Siddhartha¹ (AUTHOR)

Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia.

Yang, Zhao^1,2 (AUTHOR) zhao.yang@bjmu.edu.cn, Li, Yiran³ (AUTHOR) liyiran@ucass.edu.com, Liu, Siyu⁴ (AUTHOR) liusiyu7@sxmu.edu.cn, Han, Xiao⁵ (AUTHOR) seantxq@sina.com, Wu, Yongyi⁶ (AUTHOR) wuyongyi@kmmu.edu.cn, Fan, Xiaohan⁷ (AUTHOR) xiaohanf@bjmu.edu.cn, Li, Yuan⁸ (AUTHOR) drliyuan75@163.com, Jiang, Bin^2,9 (AUTHOR) binjiang@bjmu.edu.cn

5-FU@HFn combined with decitabine induces pyroptosis and enhances antitumor immunotherapy for chronic myeloid leukemia.

Yuan, Zuowei^1,2 (AUTHOR), Jiang, Guoyun^1,3 (AUTHOR), Yuan, Ying⁴ (AUTHOR), Liang, Qian⁵ (AUTHOR), Hou, Yaxin⁶ (AUTHOR), Zhang, Wenyao¹ (AUTHOR), Tang, Lujia¹ (AUTHOR), Fan, Kelong^5,6 (AUTHOR) fankelong@ibp.ac.cn, Feng, Wenli¹ (AUTHOR) fengwl@cqmu.edu.cn

Tyrosine kinase inhibitor discontinuation and reinitiation patterns in CML patients in the US: real-world evidence.

Sarker, Jyotirmoy¹ (AUTHOR) jsarke3@uic.edu, Atallah, Ehab L.² (AUTHOR), Flynn, Kathryn E.² (AUTHOR), Winn, Aaron N.¹ (AUTHOR)

Cases of Patients Treated in Countries With Limited Resources and Discussed by Experts of the International CML Foundation (iCMLf)—Case No. 2: Treatment‐Free Remission After 9 Years of Imatinib Treatment Without Prior Achievement of Sustained Deep Molecular Response

Michalowski, Mariana Bohns¹ (AUTHOR), Suttorp, Meinolf² (AUTHOR), Harriss-Buchan, Arlene³ (AUTHOR), Saglio, Guiseppe⁴ (AUTHOR), Evans, Nicola³ (AUTHOR), Roy Moulik, Nirmalya⁵ (AUTHOR) roymoulik@gmail.com, Mayordomo, Jose I. (AUTHOR) josemayordomo@hotmail.com

Utilization of Machine Learning in the Prediction, Diagnosis, Prognosis, and Management of Chronic Myeloid Leukemia.

Stagno, Fabio¹ (AUTHOR), Russo, Sabina^1,2 (AUTHOR), Murdaca, Giuseppe^2,3 (AUTHOR) giuseppe.murdaca@unige.it, Mirabile, Giuseppe^1,4 (AUTHOR), Alvaro, Maria Eugenia¹ (AUTHOR), Nasso, Maria Elisa^1,2 (AUTHOR), Zemzem, Mohamed^1,3 (AUTHOR), Gangemi, Sebastiano⁴ (AUTHOR), Allegra, Alessandro¹ (AUTHOR)

Frequency, distribution, and impact on prognosis of BCR-ABL1 kinase domain mutations in tyrosine kinase inhibitor resistant chronic myelogenous leukemia patients.

AKAR, Ömer Salih¹ omersalih.akar@omu.edu.tr, TURGUT, Mehmet², ÖZATLI, Düzgün², ABUR, Ümmet¹, KELKİTLİ, Engin², ALTUNDAĞ, Engin¹, OĞUR, Gönül¹

Contrastive Mask Learning for Self-Supervised 3D Skeleton-Based Action Recognition.

Zhang, Haoyuan¹ (AUTHOR)